New research has uncovered the key mechanism behind the interaction between small heat shock proteins and other proteins key in the development of neurodegenerative diseases.
Browsing: Cognitive/neurodegenerative disorders
This editorial explores nonpharmacological treatment options for psychosis in Parkinson’s disease, drawing lessons from pre-existing dementia and schizophrenia literature.
Neurology Central talks to Johan Vos, Deputy Executive Director of Alzheimer’s Disease International about the charity’s work and the key findings of the 2015 World Alzheimer Report.
Neurology Central finds out more about ARUK and the key projects they are funding for Alzheimer’s disease research.
International experts call for changes in the treatment and management of Multiple Sclerosis at ECTRIMS.
The propensity of a protein to form amyloid assemblies is imprinted in its sequence and can be read using computational approaches. This article utilizes four different algorithms to analyze the presence of aggregation-prone regions in the sequence and structure of neuroreceptors.
Preclinical study demonstrates that multiple sclerosis nerve repair could be initiated by partial blockade of a cancer-promoting pathway, providing new hope for therapeutics.
Jose Spring gives us a brief overview of her work investigating therapeutic gardening for patients with neurodisability and dementia in both the UK and Scandinavia.
A new study has indicated that high levels of TREM2 within monocytes are linked to an increased risk of Alzheimer’s disease. The study results help to further unravel the role of the immune system within the disease.
The use of dopamine agonists for Parkinson’s treatment is often associated with unwanted side effects. This review identifies strategies for managing or avoiding these effects and discusses future needs to improve the understanding of these phenomena.